A Phase II study of dasatinib in patients with chemo-sensitive relapsed small cell lung cancer (SCLC): CALGB 30602

Journal Article

Full Text

Duke Authors

Cited Authors

  • Miller, AA; Pang, H; Hodgson, L; Ramnath, N; Otterson, GA; Vokes, EE

Published Date

  • September 2009

Published In

Volume / Issue

  • 4 / 9

Start / End Page

  • S816 - S817

International Standard Serial Number (ISSN)

  • 1556-0864